TTR and axonal neuropathy: Recognizing that these case numbers were too low to be representative for statistical analyses, the UPSS still tended to be higher in symptomatic patients compared to pre-symptomatic TTR mutation carriers and to other axonal neuropathy patients (CMT2, mean = 1.33 ± 1.45).